Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-18-021023)

Filing Details

Accession Number:: 0001127602-18-021023
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-15 14:19:11
Reporting Period:: 2018-06-15

Accepted Time:: 2018-06-15 14:19:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1705843	Calyxt Inc.	CLXT	Biological Products, (No Disgnostic Substances) (2836)	I0

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1627281	S.a. Cellectis	8, Rue De La Croix Jarry 75013 Paris, I0		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-15	63,175	$19.49	22,713,175	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These shares were purchased pursuant to Share Purchase Agreements, dated June 13, 2018, from individuals with Restricted Stock Units of Calyxt, Inc. vesting on June 14, 2018 at the closing price of the shares on The Nasdaq Global Market on June 14, 2018. The reporting person undertakes to provide the staff of the SEC, upon request, full information regarding the number of shares purchased from each individual.